From Animal Testing to Organoids: The New Era of Human-Based Drug Development

The FDA’s move to phase out animal testing marks a pivotal shift in drug development, opening the door for human-based models like organoids and organ-on-a-chip systems to drive safer, more precise, and patient-relevant discoveries. The post From Animal Testing to Organoids: The New Era of Human-Based Drug Development appeared first on Parse Biosciences .